Literature DB >> 16230202

A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole.

B Clark1, R Foster, A Tunbridge, S Green.   

Abstract

A 79-year-old man with a 3-month history of weight loss and fever was diagnosed with disseminated histoplasmosis. When the infection became refractory to itraconazole therapy, posaconazole was prescribed. The patient became asymptomatic within 1 month of beginning treatment, and his general health improved. Posaconazole was discontinued after 6 months, and the patient has remained well since.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230202     DOI: 10.1016/j.jinf.2005.01.001

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

Review 1.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Bats, fever and adenopathy - what is the link?

Authors:  Joshua J Manolakos; Mohan Cooray; Ameen Patel; Shariq Haider
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 3.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Histoplasmosis Masquerading as a Rheumatoid Nodule in an Immunocompromised Host: A Case Report.

Authors:  April C Pettit; Martin B Raynor; Herbert S Schwartz; Patty W Wright
Journal:  JBJS Case Connect       Date:  2014

5.  The role of second-generation antifungal triazoles for treatment of the endemic mycoses.

Authors:  Alison G Freifeld; J Ryan Bariola; David Andes
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.